Tetratherix Limited (ASX:TTX)
6.25
-0.30 (-4.58%)
Nov 17, 2026, 10:16 AM AEDT
Tetratherix Market Cap
Tetratherix has a market cap or net worth of 331.61 million as of November 16, 2026. It is the 19,654th most valuable company in the world and the 370th biggest in Australia. Its market cap has increased by 65.13% in one year.
Market Cap
331.61M
Enterprise Value
308.22M
Revenue
3.86M
Global Rank
Country Rank
#370 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since June 30, 2025, Tetratherix's market cap has increased from 152.00M to 331.61M, an increase of 118.17%. That is a compound annual growth rate of 75.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 347.53M | 110.51% |
| Dec 30, 2025 | 165.09M | 8.61% |
| Jun 30, 2025 | 152.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 677.14M |
| Clinuvel Pharmaceuticals | 374.18M |
| Racura Oncology | 308.81M |
| Starpharma Holdings | 203.89M |
| BLS Pharmaceuticals | 196.91M |
| Actinogen Medical | 173.15M |
| Paradigm Biopharmaceuticals | 153.48M |
| Orthocell | 152.54M |